Literature DB >> 14668988

[Misdiagnosis of urinalysis due to in vivo formation of urinary stones].

N Laube1, M Pullmann, S Hergarten, M Schmidt, A Hesse.   

Abstract

The occurrence of biochemically unaltered urinalyses in patients with severe recurrent stone formation is not a rare observation in practice. The possible reasons for that phenomenon are manifold. We show that stone growth-related urinary depletion of lithogenic constituents caused by acute growth of urinary calculi in vivo can be an important reason for the observed phenomenon. The described process which can strongly influence the urinary composition occurs in any stone-bearing patient. Thus, it is strongly recommended that stone-related alterations be taken into account when interpreting the urinalyses of these patients. Based on simplified model assumptions, the extent of the expected chemical depletion effect can be calculated for any stone patient's urine sample. In two easy-to-use nomograms, we have combined the key parameters which govern the process, allowing the user a fast and easy estimation.

Entities:  

Mesh:

Year:  2003        PMID: 14668988     DOI: 10.1007/s00120-003-0445-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  4 in total

1.  Contribution of dietary oxalate to urinary oxalate excretion.

Authors:  R P Holmes; H O Goodman; D G Assimos
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

Review 2.  Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.

Authors:  W G Robertson; H Hughes
Journal:  Scanning Microsc       Date:  1993-03

3.  Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

4.  Influence of urinary stones on the composition of a 24-hour urine sample.

Authors:  Norbert Laube; Michael Pullmann; Stefan Hergarten; Albrecht Hesse
Journal:  Clin Chem       Date:  2003-02       Impact factor: 8.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.